303 related articles for article (PubMed ID: 10482217)
1. Myeloid colony-stimulating factors: use in the newborn.
Sreenan C; Osiovich H
Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
[TBL] [Abstract][Full Text] [Related]
2. G-CSF and GM-CSF for treating or preventing neonatal infections.
Carr R; Modi N; Doré C
Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
[TBL] [Abstract][Full Text] [Related]
3. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
Castagnola E; Dufour C
Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
[TBL] [Abstract][Full Text] [Related]
5. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
Lehrnbecher T
Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
[TBL] [Abstract][Full Text] [Related]
6. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates.
Bracho F; Goldman S; Cairo MS
Curr Opin Hematol; 1998 May; 5(3):215-20. PubMed ID: 9664163
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
[TBL] [Abstract][Full Text] [Related]
8. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
Lehrnbecher T
Klin Padiatr; 2001; 213(4):212-38. PubMed ID: 11528556
[TBL] [Abstract][Full Text] [Related]
9. Use of myeloid colony-stimulating factors in neonates with septicemia.
Bernstein HM; Calhoun DA; Christensen RD
Curr Opin Pediatr; 2002 Feb; 14(1):91-4. PubMed ID: 11880741
[TBL] [Abstract][Full Text] [Related]
10. Rationale and potential use of cytokines in the prevention and treatment of neonatal sepsis.
Goldman S; Ellis R; Dhar V; Cairo MS
Clin Perinatol; 1998 Sep; 25(3):699-710. PubMed ID: 9779342
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
Carr R; Modi N; Doré CJ; El-Rifai R; Lindo D
Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
Wright DG; Kenney RF; Oette DH; LaRussa VF; Boxer LA; Malech HL
Blood; 1994 Aug; 84(4):1257-67. PubMed ID: 7519479
[TBL] [Abstract][Full Text] [Related]
13. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
Liang DC
Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
[TBL] [Abstract][Full Text] [Related]
14. Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended?
Del Vecchio A; Christensen RD
Early Hum Dev; 2012 May; 88 Suppl 2():S19-24. PubMed ID: 22633505
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
Carr R; Brocklehurst P; Doré CJ; Modi N
Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte macrophage-colony stimulating factor (GM-CSF) in neonatal neutropenia.
Ray M; Mukhopadhyay K; Narang A
Indian J Pediatr; 2000 Jan; 67(1):67-8. PubMed ID: 10832225
[TBL] [Abstract][Full Text] [Related]
17. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
Ahmad A; Laborada G; Bussel J; Nesin M
Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
[TBL] [Abstract][Full Text] [Related]
18. Role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of patients with HIV infection.
Frumkin LR
Curr Opin Hematol; 1997 May; 4(3):200-6. PubMed ID: 9209837
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
20. Effect of granulocyte and granulocyte macrophage colony stimulating factors (G-CSF and GM-CSF) on neonatal neutrophil functions.
Wolach B; Gavrieli R; Pomeranz A
Pediatr Res; 2000 Sep; 48(3):369-73. PubMed ID: 10960505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
